“Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes: A Narrative Review of Who Needs Fibrosis Staging and When”, JCDO, vol. 3, no. 1, pp. 19–24, Sep. 2023, doi: 10.5281/zenodo.22258263.